TickerFactsScreenerDevelopers

HERON THERAPEUTICS, INC. /DE/ (HRTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $9.97M2009: $7.59M2010: $2.11M2011: $17.97M2012: $53.51M2013: $72.29M2014: $72.67M2015: $75.18M2016: $13.41M2017: $144.58M2018: $31.84M2019: $71.90M2020: $105.14M2021: $90.54M2022: $15.36M2023: $28.68M2024: $25.80M2025: $28.65M$28.65M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$28.65M+11.0%
2024$25.80M-10.0%
2023$28.68M+86.7%
2022$15.36M-83.0%
2021$90.54M-13.9%
2020$105.14M+46.2%
2019$71.90M+125.8%
2018$31.84M-78.0%
2017$144.58M+977.9%
2016$13.41M-82.2%
2015$75.18M+3.4%
2014$72.67M+0.5%
2013$72.29M+35.1%
2012$53.51M+197.7%
2011$17.97M+752.3%
2010$2.11M-72.2%
2009$7.59M-23.8%
2008$9.97M—